Cargando…

Longitudinal mortality of preserved ratio impaired spirometry in a middle-aged Asian cohort

BACKGROUND: Although preserved ratio impaired spirometry (PRISm) has been determined to have poor prognosis, it is a heterogeneous state, and studies regarding its prognosis in Asians are limited. This study investigated the long-term all-cause and cardiovascular mortality of patients with PRISm com...

Descripción completa

Detalles Bibliográficos
Autores principales: Sin, Sooim, Lee, Eun Ju, Won, Sungho, Kim, Woo Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157957/
https://www.ncbi.nlm.nih.gov/pubmed/37138264
http://dx.doi.org/10.1186/s12890-023-02451-2
_version_ 1785036862416486400
author Sin, Sooim
Lee, Eun Ju
Won, Sungho
Kim, Woo Jin
author_facet Sin, Sooim
Lee, Eun Ju
Won, Sungho
Kim, Woo Jin
author_sort Sin, Sooim
collection PubMed
description BACKGROUND: Although preserved ratio impaired spirometry (PRISm) has been determined to have poor prognosis, it is a heterogeneous state, and studies regarding its prognosis in Asians are limited. This study investigated the long-term all-cause and cardiovascular mortality of patients with PRISm compared with those of patients with chronic obstructive pulmonary disease (COPD) and normal individuals in the Korean middle-aged general population. METHODS: Participants were recruited between 2001 and 2002 from a community-based prospective cohort in South Korea. Mortality data were collected over a 16.5-year mean follow-up period. The all-cause and cardiovascular mortality risks of PRISm were compared between patients with COPD and healthy controls. RESULTS: The PRISm group had a mean age of 53.4 years and mean body mass index of 24.9 kg/m(2); furthermore, 55.2% of the PRISm patients had never smoked, and the prevalence of comorbidities was not higher than that in the other groups. Compared with normal individuals, PRISm patients did not show increased all-cause mortality, whereas COPD patients showed increased all-cause mortality (PRISm: adjusted hazard ratio [aHR], 1.19; 95% confidence interval [CI], 0.85–1.65; COPD: aHR, 1.34, 95% CI, 1.07–1.69). Furthermore, the PRISm patients did not show increased cardiovascular mortality compared with normal individuals (PRISm: aHR, 1.65; 95% CI, 0.92–2.95; COPD: aHR, 1.83; 95% CI, 1.09–3.07). CONCLUSION: In our population-based cohort, all-cause and cardiovascular mortality risk did not increase in individuals with PRISm compared with normal individuals. Further studies are needed to distinguish a lower-risk subgroup of PRISm with certain characteristics, such as middle-aged, light-smoking Asians without additional cardiovascular risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-023-02451-2.
format Online
Article
Text
id pubmed-10157957
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101579572023-05-05 Longitudinal mortality of preserved ratio impaired spirometry in a middle-aged Asian cohort Sin, Sooim Lee, Eun Ju Won, Sungho Kim, Woo Jin BMC Pulm Med Research BACKGROUND: Although preserved ratio impaired spirometry (PRISm) has been determined to have poor prognosis, it is a heterogeneous state, and studies regarding its prognosis in Asians are limited. This study investigated the long-term all-cause and cardiovascular mortality of patients with PRISm compared with those of patients with chronic obstructive pulmonary disease (COPD) and normal individuals in the Korean middle-aged general population. METHODS: Participants were recruited between 2001 and 2002 from a community-based prospective cohort in South Korea. Mortality data were collected over a 16.5-year mean follow-up period. The all-cause and cardiovascular mortality risks of PRISm were compared between patients with COPD and healthy controls. RESULTS: The PRISm group had a mean age of 53.4 years and mean body mass index of 24.9 kg/m(2); furthermore, 55.2% of the PRISm patients had never smoked, and the prevalence of comorbidities was not higher than that in the other groups. Compared with normal individuals, PRISm patients did not show increased all-cause mortality, whereas COPD patients showed increased all-cause mortality (PRISm: adjusted hazard ratio [aHR], 1.19; 95% confidence interval [CI], 0.85–1.65; COPD: aHR, 1.34, 95% CI, 1.07–1.69). Furthermore, the PRISm patients did not show increased cardiovascular mortality compared with normal individuals (PRISm: aHR, 1.65; 95% CI, 0.92–2.95; COPD: aHR, 1.83; 95% CI, 1.09–3.07). CONCLUSION: In our population-based cohort, all-cause and cardiovascular mortality risk did not increase in individuals with PRISm compared with normal individuals. Further studies are needed to distinguish a lower-risk subgroup of PRISm with certain characteristics, such as middle-aged, light-smoking Asians without additional cardiovascular risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-023-02451-2. BioMed Central 2023-05-03 /pmc/articles/PMC10157957/ /pubmed/37138264 http://dx.doi.org/10.1186/s12890-023-02451-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Sin, Sooim
Lee, Eun Ju
Won, Sungho
Kim, Woo Jin
Longitudinal mortality of preserved ratio impaired spirometry in a middle-aged Asian cohort
title Longitudinal mortality of preserved ratio impaired spirometry in a middle-aged Asian cohort
title_full Longitudinal mortality of preserved ratio impaired spirometry in a middle-aged Asian cohort
title_fullStr Longitudinal mortality of preserved ratio impaired spirometry in a middle-aged Asian cohort
title_full_unstemmed Longitudinal mortality of preserved ratio impaired spirometry in a middle-aged Asian cohort
title_short Longitudinal mortality of preserved ratio impaired spirometry in a middle-aged Asian cohort
title_sort longitudinal mortality of preserved ratio impaired spirometry in a middle-aged asian cohort
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157957/
https://www.ncbi.nlm.nih.gov/pubmed/37138264
http://dx.doi.org/10.1186/s12890-023-02451-2
work_keys_str_mv AT sinsooim longitudinalmortalityofpreservedratioimpairedspirometryinamiddleagedasiancohort
AT leeeunju longitudinalmortalityofpreservedratioimpairedspirometryinamiddleagedasiancohort
AT wonsungho longitudinalmortalityofpreservedratioimpairedspirometryinamiddleagedasiancohort
AT kimwoojin longitudinalmortalityofpreservedratioimpairedspirometryinamiddleagedasiancohort